Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Solazyme Company Profile (NASDAQ:SZYM)

Consensus Ratings for Solazyme (NASDAQ:SZYM) (?)
Ratings Breakdown: 6 Hold Rating(s), 1 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Hold (Score: 2.38)
Consensus Price Target: $5.29 (67.80% upside)

Analysts' Ratings History for Solazyme (NASDAQ:SZYM)
Show:
DateFirmActionRatingPrice TargetActions
5/22/2015Vetr Inc.UpgradeBuy -> Strong-Buy$6.10View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015Vetr Inc.UpgradeBuy -> Strong-Buy$5.57View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2015Cowen and CompanyReiterated RatingMarket Perform$3.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015ZacksUpgradeSell -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2015ZacksDowngradeNeutral$2.90View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2014Morgan StanleyDowngradeOverweight -> Equal Weight$15.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2014Credit SuisseReiterated RatingNeutral$11.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2014Roth CapitalInitiated CoverageBuy$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2014Cowen and CompanyDowngradeOutperform -> Market Perform$12.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2014Pacific CrestDowngradeOutperform -> Sector PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2014Robert W. BairdDowngradeOutperform -> Neutral$16.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/30/2014Morgan StanleyReiterated RatingOverweight$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2014Credit SuisseLower Price Target$12.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2014Cowen and CompanyBoost Price Target$17.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2014Robert W. BairdLower Price Target$18.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2014Goldman SachsDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2014Cowen and CompanyBoost Price Target$14.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2014Robert W. BairdBoost Price Target$16.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2013Credit SuisseDowngradeOutperform -> Neutral$17.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/25/2013Goldman SachsReiterated RatingBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2013Robert W. BairdBoost Price TargetOutperform$12.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2013Piper JaffrayReiterated RatingUnderweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2013Morgan StanleyReiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2013Jefferies GroupReiterated RatingBuy$18.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2013Raymond JamesBoost Price TargetOutperform$10.50 -> $12.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/23/2013 forward)